Pfizer holds a lead in the erectile dysfunction market even as generics erode sales of its once-blockbuster male libido treatment, Viagra. According to GoodRx, 65% of ED prescriptions filled from Dec. 1, 2018, to Jan. 31, 2019, were for Viagra or its generic version.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,